ad-209
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jan 28, 2020 (NCT04218552)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06348576 | Phase 3 | May 20, 2024 | Addpharma Inc., Korea University |
| NCT05631990 | Phase 2 | Apr 30, 2023 | Addpharma Inc., Korea University |
| NCT04218552 | Phase 2 | Jan 28, 2020 | Addpharma Inc., Korea University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Addpharma Inc. | For profit | 3 | 3 | 2 | 2020 |
| Korea University | Academic/Hospital | 3 | 0 | 2 | 2020 |
2 organizations
Page 1 / 1